Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated:  10/30/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated: 10/30/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated:  10/30/2017
Metro-Minnesota CCOP
mi
from
Saint Louis Park, MN
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated: 10/30/2017
Metro-Minnesota CCOP
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated:  10/30/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated: 10/30/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated:  10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated: 10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated:  10/30/2017
Chinese University of Hong Kong-Prince of Wales Hospital
mi
from
Shatin,
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Status: Enrolling
Updated: 10/30/2017
Chinese University of Hong Kong-Prince of Wales Hospital
mi
from
Shatin,
Click here to add this to my saved trials
Increasing Implementation of Evidence-based Interventions at Low-wage Worksites
Increasing Implementation of Evidence-based Interventions at Low-wage Worksites
Status: Enrolling
Updated:  10/30/2017
University of Washington Health Promotion Research Center
mi
from
Seattle, WA
Increasing Implementation of Evidence-based Interventions at Low-wage Worksites
Increasing Implementation of Evidence-based Interventions at Low-wage Worksites
Status: Enrolling
Updated: 10/30/2017
University of Washington Health Promotion Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Investigation on the Utility of Advanced MRI Imaging Methods for Radiation Therapy Treatment Planning
Status: Enrolling
Updated:  10/30/2017
Froedtert Hospital
mi
from
Milwaukee, WI
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Investigation on the Utility of Advanced MRI Imaging Methods for Radiation Therapy Treatment Planning
Status: Enrolling
Updated: 10/30/2017
Froedtert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated:  10/30/2017
Bellevue Hospital
mi
from
New York, NY
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 10/30/2017
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated:  10/30/2017
NYU Cancer Institute
mi
from
New York, NY
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 10/30/2017
NYU Cancer Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
Phase I/II Study of Myeloablative Allogeneic Stem Cell Transplantation for Aggressive Hematologic Malignancies Using Clofarabine and Busulfan x 4 (Clo/BU4) Regimen
Status: Enrolling
Updated:  10/30/2017
University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program
mi
from
Ann Arbor, MI
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
Phase I/II Study of Myeloablative Allogeneic Stem Cell Transplantation for Aggressive Hematologic Malignancies Using Clofarabine and Busulfan x 4 (Clo/BU4) Regimen
Status: Enrolling
Updated: 10/30/2017
University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated:  10/31/2017
Veterans Affairs Palo Alto
mi
from
Palo Alto, CA
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated: 10/31/2017
Veterans Affairs Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated:  10/31/2017
Veterans Affairs San Francisco
mi
from
San Francisco, CA
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated: 10/31/2017
Veterans Affairs San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated:  10/31/2017
Veterans Affairs Kansas City
mi
from
Kansas City, MO
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
Full Inspection With Narrow Band Imaging (NBI) for Detection of Flat Lesions And Tumors During Colonoscopy- The FIND FLAT Colonoscopy Study
Status: Enrolling
Updated: 10/31/2017
Veterans Affairs Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer
Status: Enrolling
Updated:  10/31/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer
Status: Enrolling
Updated: 10/31/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
Randomized Phase II Study Comparing Stereotactic Body Radiotherapy (SBRT) With Stereotactic Body Proton Therapy (SBPT) for Centrally Located Stage I, Selected Stage II and Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  10/31/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
Randomized Phase II Study Comparing Stereotactic Body Radiotherapy (SBRT) With Stereotactic Body Proton Therapy (SBPT) for Centrally Located Stage I, Selected Stage II and Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 10/31/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Stanford University School of Medicine
mi
from
Stanford, CA
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Markey Cancer Center, Clinical Research Office
mi
from
Lexington, KY
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Markey Cancer Center, Clinical Research Office
mi
from
Lexington, KY
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Froedtert Hospital, Medicial College of Wisconsin
mi
from
Milwaukee, WI
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Froedtert Hospital, Medicial College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated:  10/31/2017
Montefiore
mi
from
Bronx, NY
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
Status: Enrolling
Updated: 10/31/2017
Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Randomized Phase II Trial of Sequential Versus Concurrent Docetaxel and PS-341 (NSC 681239) in Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  10/31/2017
City of Hope Medical Center
mi
from
Duarte, CA
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Randomized Phase II Trial of Sequential Versus Concurrent Docetaxel and PS-341 (NSC 681239) in Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 10/31/2017
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Boston, MA
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Buffalo, NY
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
New York, NY
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Rochester, NY
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated:  11/1/2017
Site Reference ID/Investigator# 8941
mi
from
Edmonton,
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Enrolling
Updated: 11/1/2017
Site Reference ID/Investigator# 8941
mi
from
Edmonton,
Click here to add this to my saved trials
Imaging and Biomarkers of Hypoxia in Solid Tumors
Imaging and Biomarkers of Hypoxia in Solid Tumors
Status: Enrolling
Updated:  11/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Imaging and Biomarkers of Hypoxia in Solid Tumors
Imaging and Biomarkers of Hypoxia in Solid Tumors
Status: Enrolling
Updated: 11/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
A Phase II Study of Docetaxel/Cisplatin/5-Fluorouracil (TPF) Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Using a Modified Radiation Dose in Patients With Newly Diagnosed HPV Positive, Locally Advanced Squamous Cell Carcinoma of the Oropharynx
Status: Enrolling
Updated:  11/1/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
A Phase II Study of Docetaxel/Cisplatin/5-Fluorouracil (TPF) Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Using a Modified Radiation Dose in Patients With Newly Diagnosed HPV Positive, Locally Advanced Squamous Cell Carcinoma of the Oropharynx
Status: Enrolling
Updated: 11/1/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Chicago, IL
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Lebanon, NH
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Stony Brook, NY
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Houston, TX
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Greenville, SC
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
San Antonio, TX
A Study of AMG 820 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
R01 CA155301: Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Status: Enrolling
Updated:  11/1/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
R01 CA155301: Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Status: Enrolling
Updated: 11/1/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer
Status: Enrolling
Updated:  11/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer
Status: Enrolling
Updated: 11/1/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)
Status: Enrolling
Updated:  11/1/2017
University of California at San Francisco
mi
from
San Francisco, CA
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)
Status: Enrolling
Updated: 11/1/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer
Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer
Status: Enrolling
Updated:  11/1/2017
Vanderbilt Univeristy
mi
from
Nashville, TN
Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer
Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer
Status: Enrolling
Updated: 11/1/2017
Vanderbilt Univeristy
mi
from
Nashville, TN
Click here to add this to my saved trials
Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Pre-Surgical Detection of Colorectal Carcinomas Using 123Iodine-Labeled cT84.66 Diabody Antibody Fragments to Carcinoembryonic Antigen (CEA)
Status: Enrolling
Updated:  11/2/2017
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Pre-Surgical Detection of Colorectal Carcinomas Using 123Iodine-Labeled cT84.66 Diabody Antibody Fragments to Carcinoembryonic Antigen (CEA)
Status: Enrolling
Updated: 11/2/2017
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  11/2/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 11/2/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated:  11/2/2017
City of Hope
mi
from
Duarte, CA
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
A Pilot Study Investigating the Feasibility of Using Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy
Status: Enrolling
Updated: 11/2/2017
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated:  11/2/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated: 11/2/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated:  11/2/2017
National Institutes of Health, National Cancer Institute
mi
from
Bethesda, MD
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated: 11/2/2017
National Institutes of Health, National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated:  11/2/2017
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Status: Enrolling
Updated: 11/2/2017
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials